Federal Register of Legislation - Australian Government

Primary content

This instrument is a notification that the Minister's delegate has exercised discretion under subsection 99ACF(3) of the National Health Act 1953 to not apply anniversary price reductions that would otherwise apply to the specified drugs on 1 April 2019.
Administered by: Health
Registered 29 Mar 2019

 

 

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ACF(3) of the National Health Act 1953.

Dated    27 March 2019

 

 

 

 

 

 

 

 

 

THEA DANIEL

 

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

 

 

 

 

 

1              Name of Determination

                This instrument is the National Health (April 2019 Anniversary statutory price reduction) (Exercise of Ministerial discretion) Determination 2019.  

2              Commencement

                This instrument commences on the day it is made.

3              Definition

 

              Note: A number of expressions used in this instrument are defined in Part VII the Act,

 

In this instrument:

  

   Act means the National Health Act 1953.

 

price reduction day has the same meaning as in section 99ACL of the Act.

4              Authority

 

This instrument is made under subsection 99ACF(3) of the Act.

5              Brand of pharmaceutical item not subject to a price reduction

 

                I determine, under paragraph 99ACF(3)(a) of the Act, that the approved ex-manufacturer price of each brand of pharmaceutical item specified in column 2  as an item in the table in Schedule 1 is not reduced under a provision mentioned in item 5 or 6 of the table in subsection 99ACF(1) of the Act, as appropriate, in relation to the price reduction day.

 

            


Schedule 1 Brands of pharmaceutical items with approved ex-manufacturer price not reduced

 

Column 1

Column 2

Item

Brand of Pharmaceutical Item

 

Drug

Form

Manner of administration

Brand

1

Deferiprone

Oral solution 100 mg per mL, 250 mL

Oral

Ferriprox

2

Deferiprone

Tablet 500 mg

Oral

Ferriprox

3

Glycomacropeptide and essential amino acids with vitamins and minerals

Bars 81 g, 14 (Tylactin Complete)

Oral

Tylactin Complete

4

Glycomacropeptide and essential amino acids with vitamins and minerals

Bars 81 g, 7 (Camino Pro Complete)

Oral

Camino Pro Complete

5

Glycomacropeptide and essential amino acids with vitamins and minerals

Oral liquid 250 mL, 30 (PKU Glytactin RTD 15 Lite)

Oral

PKU Glytactin RTD 15 Lite

 

6

Glycomacropeptide and essential amino acids with vitamins and minerals

Oral liquid 250 mL, 30 (PKU Glytactin RTD 15)

Oral

PKU Glytactin RTD 15

 

7

Glycomacropeptide and essential amino acids with vitamins and minerals

Oral liquid 250 mL, 30 (Tylactin RTD)

Oral

Tylactin RTD

 

8

Glycomacropeptide and essential amino acids with vitamins and minerals

Sachets containing oral powder 16 g, 60 (PKU Build 10)

Oral

PKU Build 10

 

9

Glycomacropeptide and essential amino acids with vitamins and minerals

Sachets containing oral powder 20 g, 60 (PKU Restore)

Oral

PKU Restore

 

10

Glycomacropeptide and essential amino acids with vitamins and minerals

Sachets containing oral powder 32 g, 30 (PKU Build 20)

Oral

PKU Build 20

 

11

Glycomacropeptide and essential amino acids with vitamins and minerals

Sachets containing oral powder 49 g, 30 (Camino Pro Bettermilk)

Oral

Camino Pro Bettermilk

12

Glycomacropeptide and essential amino acids with vitamins and minerals

Sachets containing oral powder 51 g, 30 (PKU Bettermilk Lite)

Oral

PKU Bettermilk Lite